The pharmaceutical industry stands at a critical juncture, contending with a deep and persistent deficit of public trust that can significantly impede medical progress and patient care. While this challenge is formidable, it is not an insurmountable barrier to a more collaborative future. Recent
With a deep background in biopharma and a keen eye on the intersection of technology and research, Ivan Kairatov has become a leading voice on innovative public health strategies. Today, he joins us to discuss a unique cause-marketing campaign that transforms the retail experience into a powerful
In the high-stakes world of pharmaceutical development, not all clinical successes translate to commercial triumphs, a reality starkly illustrated when Amgen announced it was terminating its partnership with Kyowa Kirin for the eczema drug rocatinlimab, handing back the rights to a once-promising
A groundbreaking personalized cancer therapy that essentially teaches a patient's own immune system how to recognize and destroy their specific tumor has delivered remarkable results in its initial human trial, signaling a potential new era in the fight against advanced solid tumors. This
The intricate connection between what we eat and how we feel extends far beyond calories and vitamins, reaching into the complex world of hormones naturally present in our daily meals. While widely recognized as the body's sleep regulator, melatonin is emerging from the shadows of the circadian
For individuals living with debilitating genetic skin disorders, effective treatments have remained elusive, often limited to managing symptoms rather than addressing the root cause encoded in their DNA. A groundbreaking development from researchers at the University of British Columbia and the
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38